Product Code: ETC5634655 | Publication Date: Nov 2023 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
The cardiac marker testing market in Angola is also influenced by advancements in diagnostic technologies, increasing healthcare expenditure, and government initiatives to improve healthcare infrastructure. Rapid urbanization and lifestyle changes leading to higher incidences of cardiovascular risk factors like obesity and diabetes are further driving market growth. Healthcare providers are adopting cardiac marker testing for timely intervention and effective management of heart conditions, thereby boosting market demand.
Increasing prevalence of cardiovascular diseases drives the Angola cardiac marker testing market. Demand for early disease detection and monitoring tools, including biomarkers and diagnostic tests, supports market growth in healthcare settings.
The cardiac marker testing market in Angola encounters challenges related to healthcare infrastructure and diagnostic technology adoption. Improving accessibility to advanced diagnostic facilities and equipment in remote regions of Angola remains a critical challenge for healthcare providers and diagnostic laboratories. Moreover, integrating innovative cardiac biomarker testing technologies with existing healthcare systems requires strategic investments in medical training and technology deployment, influencing market penetration and patient care outcomes in Angola.
Angola`s policies on cardiac marker testing prioritize healthcare quality improvement, disease prevention, and medical research advancement. Government initiatives include regulatory standards for diagnostic tests, healthcare infrastructure investments, and public health education programs.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Angola Cardiac Marker Testing Market Overview |
3.1 Angola Country Macro Economic Indicators |
3.2 Angola Cardiac Marker Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Angola Cardiac Marker Testing Market - Industry Life Cycle |
3.4 Angola Cardiac Marker Testing Market - Porter's Five Forces |
3.5 Angola Cardiac Marker Testing Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Angola Cardiac Marker Testing Market Revenues & Volume Share, By Biomarker Type, 2021 & 2031F |
3.7 Angola Cardiac Marker Testing Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.8 Angola Cardiac Marker Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Angola Cardiac Marker Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Angola Cardiac Marker Testing Market Trends |
6 Angola Cardiac Marker Testing Market Segmentations |
6.1 Angola Cardiac Marker Testing Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Angola Cardiac Marker Testing Market Revenues & Volume, By Reagents and Kits, 2021-2031F |
6.1.3 Angola Cardiac Marker Testing Market Revenues & Volume, By Instruments, 2021-2031F |
6.2 Angola Cardiac Marker Testing Market, By Biomarker Type |
6.2.1 Overview and Analysis |
6.2.2 Angola Cardiac Marker Testing Market Revenues & Volume, By Troponin I and T, 2021-2031F |
6.2.3 Angola Cardiac Marker Testing Market Revenues & Volume, By Creatine kinase-MB(CK-MB), 2021-2031F |
6.2.4 Angola Cardiac Marker Testing Market Revenues & Volume, By Natriuretic peptide (Bnp Or Nt-Probnp), 2021-2031F |
6.2.5 Angola Cardiac Marker Testing Market Revenues & Volume, By Myoglobin, 2021-2031F |
6.2.6 Angola Cardiac Marker Testing Market Revenues & Volume, By High-sensitivity C-reactive protein(hs-CRP), 2021-2031F |
6.2.7 Angola Cardiac Marker Testing Market Revenues & Volume, By Other Cardiac Biomarkers, 2021-2031F |
6.3 Angola Cardiac Marker Testing Market, By Disease |
6.3.1 Overview and Analysis |
6.3.2 Angola Cardiac Marker Testing Market Revenues & Volume, By Myocardial Infarction, 2021-2031F |
6.3.3 Angola Cardiac Marker Testing Market Revenues & Volume, By Congestive Heart Failure, 2021-2031F |
6.3.4 Angola Cardiac Marker Testing Market Revenues & Volume, By Acute Coronary Syndrome, 2021-2031F |
6.3.5 Angola Cardiac Marker Testing Market Revenues & Volume, By Atherosclerosis, 2021-2031F |
6.3.6 Angola Cardiac Marker Testing Market Revenues & Volume, By Ischemia, 2021-2031F |
6.4 Angola Cardiac Marker Testing Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Angola Cardiac Marker Testing Market Revenues & Volume, By Laboratory Testing Facilities, 2021-2031F |
6.4.3 Angola Cardiac Marker Testing Market Revenues & Volume, By Point-Of-Care Testing Facilities, 2021-2031F |
6.4.4 Angola Cardiac Marker Testing Market Revenues & Volume, By Academic Institutions, 2021-2031F |
7 Angola Cardiac Marker Testing Market Import-Export Trade Statistics |
7.1 Angola Cardiac Marker Testing Market Export to Major Countries |
7.2 Angola Cardiac Marker Testing Market Imports from Major Countries |
8 Angola Cardiac Marker Testing Market Key Performance Indicators |
9 Angola Cardiac Marker Testing Market - Opportunity Assessment |
9.1 Angola Cardiac Marker Testing Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Angola Cardiac Marker Testing Market Opportunity Assessment, By Biomarker Type, 2021 & 2031F |
9.3 Angola Cardiac Marker Testing Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.4 Angola Cardiac Marker Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Angola Cardiac Marker Testing Market - Competitive Landscape |
10.1 Angola Cardiac Marker Testing Market Revenue Share, By Companies, 2024 |
10.2 Angola Cardiac Marker Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |